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Edited by Ivan SadowskiAbstract Covalent modiﬁcation of histones regulates chromatin
structure and gene expression. Sin3A mediates the association of
histone deacetylase enzymes with a large number of sequence-
speciﬁc transcriptional repressors. In this study we characterized
three novel transcripts of SAP30L, a recently identiﬁed Sin3A-
associated protein. These splice variants show signiﬁcant diﬀer-
ences in transcriptional repression capabilities and associating
histone deacetylase activities. Furthermore, they diﬀer in binding
to Sin3A and in subcellular localization when transiently trans-
fected. These data suggest that the transcriptional repression
of a Sin3A corepressor complex can be regulated not only by se-
quence-speciﬁc transcriptional repressors, but also by modiﬁca-
tion of associated proteins, such as SAP30L.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Transcription1. Introduction
In eukaryotic cells, genetic information is organized in a
highly conserved structural polymer, chromatin. The primary
unit in chromatin is the nucleosome, composed of 146 bp of
DNA wrapped around an octamer of histone proteins.
Compacted chromatin allows eﬃcient storage of genetic infor-
mation but simultaneously forms a sterically hindered environ-
ment for the assembly of the transcription machinery.
Packaging and unpackaging of chromatin is thus intricately
regulated. One major mechanism altering the chromatin struc-
ture and gene expression is covalent modiﬁcation of histone
tails by acetylation, methylation, phosphorylation, sumoyla-
tion, ubiquitination, glycosylation, or ADP-ribosylation [1–3].
Histone deacetylation is a well-conserved mechanism for silenc-
ing gene expression [4]. Histones are typically deacetylated by
multiprotein complexes containing histone deacetylases
(HDACs) and corepressor proteins which vary depending on
the speciﬁc complex. Corepressor proteins are instrumental inAbbreviations: GST, glutathione S-transferase; HDAC, histone deace-
tylase; kDa, kilodalton; SAP30L, Sin3A-associated protein 30-like; wt,
wild-type
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doi:10.1016/j.febslet.2007.11.084establishing the speciﬁcity of a given complex. This is nicely
demonstrated by retinoblastoma protein, which recruits
HDAC complex to E2F transcription factors, leading to repres-
sion of the transcription of speciﬁc E2F-targeted genes [5].
Sin3A is a large protein composed of protein–protein interac-
tion domains and it mediates the association of heterogeneous
HDAC complexes and other chromatin-modifying proteins
with transcriptional repressors [6]. HDAC1 and HDAC2, the
histone-binding proteins RbAp46 and RbAp48, Sin3A-associ-
ated proteins SAP18, SAP30, SAP130, SAP180, and SDS3
are widely identiﬁed as core components in the Sin3A-HDAC
corepressor complex. Of the Sin3A-binding proteins, SAP30
(Sin3A-associated protein 30) and SAP30L (L for like) share
70% identity at sequence level. SAP30 is a member of the Sin3A
core complex and is thought to bridge and stabilize molecules in
the complex [7,8]. SAP30L was identiﬁed as a mRNA transcript
with increased expression due to diﬀerentiation of T84 colon
carcinoma cells by transforming growth factor b (TGF-b) [9].
Our group has recently reported that SAP30L associates with
the core members of the Sin3A corepressor complex and is able
to induce transcriptional repression presumably through Sin3A
and class I HDACs [10]. In this study, we investigated the
mRNA splice forms of SAP30L and report that the transcrip-
tional repression mediated by SAP30L can be critically inﬂu-
enced by alternative mRNA splicing.2. Materials and methods
2.1. Cloning and constructs
Human SAP30L cDNA has been described elsewhere [9]. Splice
variant cDNAs were obtained from the following IMAGE clones:
5254-i19 (DEx2), 4554-h16 (DEx2D5aa), and 6022-i24 (DEx3,4). They
were subcloned into a pcDNA3.1-myc-his expression vector (Invitro-
gen) for mammalian transfections, and pCMV-BD (Stratagene) and
pGEX-4T1 (Amersham Bioscience) vectors for the production of
Gal4- and GST-fusion proteins, respectively. The 5-residue deletion
mutant (D109–113) was created using the QuickChange Site Directed
Mutagenesis Kit (Stratagene) according to manufacturers instruc-
tions. Accuprime Pfx (Invitrogen) high-ﬁdelity DNA polymerase
was used in PCR ampliﬁcation and all of the constructs were
conﬁrmed by sequencing. pCS2 + MT-mSin3A plasmid and luciferase
reporter vector with ﬁve Gal4-binding sites and under the control of
14D promoter (5xGal4-14D-LUC) [8] were generous gifts from
D. Ayer (Salt Lake City, USA).
2.2. Identiﬁcation of mRNA splice forms
RNA isolated (RNeasy Mini Kit, Qiagen) from various cell
lines was used as template for cDNA synthesis (SuperScript II
Reverse Transcriptase, Invitrogen). SAP30L gene-speciﬁc primersblished by Elsevier B.V. All rights reserved.
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TGCTTGCCACCCTCCGAT-3 0, Proligo), located at the 5 0 end
and 3 0 end of the coding sequence, were used for the PCR ampliﬁca-
tion of splicing isoforms with AmpliTaq DNA polymerase (Applied
Biosystems). Ampliﬁed PCR products were analysed on 1% agarose
gel, subcloned into a pCR2.1-TOPO vector (Invitrogen) and
sequenced.2.3. Cell culture, immunoprecipitation, Western blot analysis, and
confocal microscopy
Human cervical carcinoma (HeLa), erythroleukemia (K-562), and
promyelocytic leukaemia (HL-60) cells were cultured in RPMI1640
(Gibco) supplemented with penicillin–streptomycin antibiotics and
10% fetal bovine serum (FBS). Human acute myeloid leukaemia
(OCI-AML3) cells were cultured in alpha-MEM (Gibco) supple-
mented with penicillin–streptomycin antibiotics and 20% FBS. Hu-
man embryonal kidney epithelial cells (HEK293T) were cultured
and transient transfections, together with immunoprecipitation (IP),
Western blotting (WB) and confocal microscopy were performed as
previously described [10]. For immunoprecipitation, the agarose-
conjugated primary antibodies used were c-myc (9E10; sc-40AC,
Santa Cruz) or His (H-3; sc-8036AC, Santa Cruz), and for
Western blotting, the primary antibodies against c-myc (9E10;
sc-40, Santa Cruz) and actin (C2; sc-8432, Santa Cruz) and the
antibody raised against the C-terminal human SAP30L peptide
(VKS-peptide: 165VKSNKSRLDQKSEGGKQLE183) were used.
The SAP30L antibody was a generous gift from Dr. Stephen Hall
(AlphaGenix, California, USA). For immunoblot analysis of human
tissues, INSTA-Blot Human tissues ready-to-use membrane (Imge-
nex) was used and probed according to manufacturers instructions.
Detection was performed as previously described [10]. For confocal
microscopy, the primary antibodies used were c-myc (A-14; sc-789,
Santa Cruz) and nucleophosmin (32-5200, Zymed).2.4. HDAC activity assay and transcriptional repression analysis
GST-pull-downs, HDAC activity measurements, and repression
analyses were performed as described by Viiri and associates [10].3. Results
3.1. Expression of SAP30L protein in human cells and tissues
To assess the expression of endogenous SAP30L protein, we
used the polyclonal antibody hereafter called the VKS, raised
against the C-terminal peptide. The ability of the VKS anti-
body to recognize SAP30L protein was ﬁrst validated against
glutathione-S-transferase (GST)-tagged recombinant SAP30L
expressed in bacteria, as illustrated in Fig. 1A (see also http://
www.alphagenix.com ). GST-SAP30 fusion protein remained
unrecognised, conﬁrming the speciﬁcity of the VKS antibody
(Fig. 1A). Transfected myc-his-tagged SAP30L migrates at
around 31–32 kilodalton (kDa) and slightly faster compared
to SAP30 [10]. This proportion correlates well with the calcu-
lated molecular weights of 20.8 kDa for SAP30L and
23.3 kDa for SAP30. Notably, in immunoblot analysis of
human cancer cell lines, the 30 kDa protein was undetectable.
Other proteins were detected, including a ubiquitous protein
of around 18 kDa (Fig. 1B). The detected proteins were almost
completely removed by pre-incubation of the antibody with the
VKS peptide, as shown in Fig. 1B, but not with an irrelevant
N-terminal SAP30L peptide (data not shown). In immunoblot
analysis of a panel of human tissues, a protein of 30 kDa size
could be detected and was strongly expressed in human brain
and ovary and weakly in heart, small intestine, kidney, lung,
skeletal muscle, stomach, and spleen (Fig. 1C). Several other
proteins were also detected. To explore the possibility of prote-
olytic processing of SAP30L, a series of protease inhibitorswere tested (PMSF, benzamidine, chymostatin, antipain, leu-
peptin, and pepstatin A), but none had eﬀects on the immuno-
blotting proﬁle elicited by the VKS antibody (data not shown).
Based on these results, we propose that the 30 kDa protein
probably represents the full-length SAP30L protein and other
forms represent degradation products, splice variants or other
post-transcriptionally modiﬁed forms of SAP30L.3.2. Characterization of SAP30L isoforms
Prompted by the above immunoblotting data and previous
Northern blotting results which suggested the presence of sev-
eral mRNA forms [9], we investigated whether SAP30L
mRNA could be alternatively spliced. For this purpose, we
extracted RNA from several cell lines and performed RT-
PCR using SAP30L-speciﬁc primers (Fig. 2A). In agarose gel
electrophoresis, 1–4 separate DNA molecules could be identi-
ﬁed and sequencing of them revealed three novel transcripts of
SAP30L. Fig. 2B illustrates the structure of the SAP30L gene
and the identiﬁed splice forms. The DEx2 splice variant is lack-
ing the second exon. The DEx2D5aa form lacks, in addition to
the second exon, also ﬁve amino acids from the third exon. The
third splice form of SAP30L, DEx3,4, consists of exons 1 and
2, and has a spliced-in sequence from the intron between exons
2 and 3 with a frameshift mutation leading to a premature stop
codon. All three splice variants have correct acceptor/donor
sequences, as shown in Fig. 2B.3.3. SAP30L isoforms diﬀer in transcriptional repression
capabilities, and associated HDAC activities
The ability of SAP30L isoforms to induce transcriptional
repression was examined using Gal4DBD fusions. In line with
our previous data, wild-type (wt) Gal4SAP30L fusion protein
repressed the transcription of a luciferase reporter containing
14D promoter and Gal4 binding sites (5xGal4-14D-LUC)
approximately 33-fold compared to Gal4 alone. The DEx2
splice form evinced a slightly reduced transcriptional repres-
sion activity compared to wt SAP30L (Fig. 3A). Surprisingly,
the DEx2D5aa variant, which lacks a further ﬁve amino acids,
had almost ﬁve times less repression activity compared to wt
SAP30L. To further elucidate this, we created a mutant
SAP30L protein lacking only these ﬁve residues (D109–113).
Repression analysis conﬁrmed the critical role played by these
residues, showing markedly reduced repression capability with
this mutant (Fig. 3A). The third splice variant, DEx3,4, which
lacks the C-terminal Sin3A-binding region, showed only minor
capability to repress transcription in this assay.
We have previously reported that SAP30L is associated with
HDAC activity and identiﬁed HDACs 1–3 as putative binding
partners for SAP30L [10]. We therefore next carried out pull-
down experiments with GST-SAP30L isoforms from
HEK293T nuclear lysates and measured the HDAC activity
in the pull-down specimens, as shown in Fig. 3B. The DEx2,
DEx2D5aa, and DEx3,4 splice forms pulled down markedly
less of HDAC activity compared to wt SAP30L whereas
D109–113 deletion mutant showed almost comparable HDAC
activity to wt SAP30L.3.4. SAP30L DEx3,4 variant is localized partly in the cytoplasm
and does not bind Sin3A
SAP30L has previously been shown to be localized in the
nucleoplasm and the nucleolus of tissue culture cells. The nu-
Fig. 2. Identiﬁcation of SAP30L mRNA splice forms. (A) RNA extracted from the indicated cell lines was used as a template for RT-PCR. The
ampliﬁed PCR products were run on an agarose gel. Arrows indicate the major bands seen on gel electrophoresis. (B) Schematic structure of the
SAP30L gene and the identiﬁed mRNA splice forms. Also depicted are the NLS and NoLS signals. GenBank Accession Nos.: wt SAP30L
(AY341060), SAP30LDEx2 (AI436556), SAP30LDEx2D5aa (AI199517) and SAP30LDEx3,4 (AI857594).
Fig. 1. Expression of endogenous SAP30L protein. (A) The speciﬁcity of the aﬃnity-puriﬁed VKS peptide antibody was tested by immunoblotting of
bacterially produced GST-SAP30L-fusion protein. As a control, GST-SAP30 fusion protein was used. (B) Immunoblot analysis of the indicated
human cancer cell lines. Peptide inhibition was performed before immunoblotting using VKS peptide of SAP30L (see Section 2). Speciﬁc protein
bands are indicated with *. (C) Immunoblot analysis of a panel of human tissues (20 lg total protein/lane).
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Fig. 3. SAP30L splice variants diﬀer in their ability to induce transcriptional repression and in the harbouring of HDAC activity. (A) HEK293T cells
were cotransfected with 5xGal4-14D luciferase reporter vector, Gal4DBD fusions and LacZ-vector as indicated. Lysed cells were analysed for
luciferase and b-Gal activity and the histogram illustrates the average fold-repressions of the Gal4DBD fusions compared to Gal4 alone. The
measurements were made in duplicate from at least two independent experiments and the error bars represent the standard deviation. (B) GST fusion
pull-downs from the HEK293T nuclear extracts were performed and HDAC activities measured with the Fluor de Lys kit as previously described
[10]. The ﬁgure shows a representative experiment made in duplicate and the error bars represent the range of measurements (AFU, arbitrary
ﬂuorescence unit).
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shown to direct the subcellular localization of SAP30L
[9,10]. In confocal microscopy of HEK293T cells, DEx3,4 iso-
form was located partly in the cytoplasm and the nucleus but
not in the nucleolus as demonstrated by double-staining with a
nucleolar marker protein nucleophosmin (Fig. 4). Other natu-
ral isoforms displayed no evident changes in subcellular local-
ization compared to wt SAP30L (Fig. 4). Notably, the DEx2
variant devoid of NLS signal was able to localize in the nucleus
suggesting that the NoLS signal is suﬃcient in directing the nu-
clear localization in this contex. An artiﬁcial deletion mutant
lacking only ﬁve residues (D109–113) showed less of the nucle-
olar staining compared to wt protein (Fig. 4).Finally, we explored whether SAP30L isoforms diﬀered in
their binding to corepressor Sin3A. Based on previous data
[10] and the above repression data, one might conceive that
the DEx3,4 variant is unable to associate with Sin3A. This
was conﬁrmed by coimmunoprecipitation experiments, as
shown in Fig. 5. The other isoforms interacted with Sin3A
comparably to wt SAP30L protein.4. Discussion
Here we report the identiﬁcation of three novel mRNA
splice forms of SAP30L and describe putative isoforms also
Fig. 4. Subcellular localization of SAP30L splice variants by confocal microscopy. HEK293T cells were transiently transfected with the myc-his-
tagged SAP30L proteins and immunostained using anti-myc antibody. Double-staining was performed by a nucleolar marker protein nucleophosmin
(NPM). Cells in the right panel were treated for 10 h with 10 lM proteasome inhibitor MG132, which has been reported to cause accumulation of
SAP30L in the nucleolus [10].
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C-terminus of SAP30L in regulating its transcriptional repres-
sion capability. Furthermore, we describe a speciﬁc ﬁve-residue
deletion mutant with severely reduced repression activity. Our
data conﬁrm that most of the repression activity of SAP30L is
probably carried out by Sin3A and HDACs. The ﬁndings shed
light on the molecular mechanisms regulating the transcrip-
tional repression of Sin3A complex through SAP30L protein.
SAP30L is regulated at several levels. First, at the level of
gene expression as shown by diverse expression of SAP30L
mRNA in separate tissues ([9], http://genome.ucsc.edu) and
by induction of expression after TGF-b-induced diﬀerentiation
of T84 cells [9]; second, at the level of post-transcriptional
modiﬁcations, as indicated by the production of alternative
mRNA splice forms; third, at the translational/post-transla-
tional level, as suggested by strong expression of SAP30L pro-
tein in e.g. the brain and weak expression in the heart, and by a
lack of 30 kDa protein in the tested cancer cell lines. All this
points to the need for tight regulation of SAP30L and here
we have begun to address this issue and have indicated that
diﬀerent isoforms of SAP30L evince functionally divergent
properties. We isolated three novel transcripts of SAP30L
which lacked some portions of the full-length protein. Thisled to varied reduction of transcriptional repression through
SAP30L, as demonstrated by Gal4-SAP30L-fusion proteins
and the luciferase reporter system. The most signiﬁcant drop
in repression activity was seen with the DEx3,4 splice variant,
where only minor activity could be detected. The DEx3,4 var-
iant was also unable to associate with Sin3A. This is consistent
with our previous data showing the inability of Sin3A to inter-
act with a C-terminally deleted SAP30L [10], and suggests that
the SAP30L repressive function is mostly carried out by the
Sin3A corepressor complex. Although DEx3,4 splice form
showed dramatically reduced repression activity, it still
retained moderate association with HDAC enzymes, highlight-
ing the functional importance of Sin3A itself in the complex.
Intriguingly, these results also suggest that the repressional
function of Sin3A corepressor complex is regulated not only
at the level of sequence-speciﬁc transcriptional repressors,
but also by associated proteins such as SAP30L.
In addition, we found markedly reduced transcriptional
repression of SAP30L after deletion of ﬁve residues in the mid-
dle of the protein. These ﬁve residues lie between the NLS and
theNoLS signals but themutation leaves them intact.We found
no evident changes in the binding to Sin3Awhereas subcellular-
ly this mutant was rarely seen in the nucleolus. Although the
Fig. 5. Association of SAP30L splice variants with Sin3A. The indicated myc-his-tagged SAP30L proteins and myc-tagged Sin3A (pCS2 + MT-
Sin3A) were cotransfected into HEK293T cells, immunoprecipitated with agarose-conjugated anti-his antibody and immunoblotted with anti-myc or
anti-VKS antibodies. Sin3A and SAP30L are indicated with arrows and the IgG light chain is marked with an *.
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unfold the three-dimensional structure of the protein and thus
change its ability to localize properly and mediate repression.
Another intriguing possibility is that the deletion of these ﬁve
residues inﬂuences the protein–protein interactions of SAP30L.
These hypotheses remain to be tested in future experiments.
In immunoblotting experiments, we found several proteins
speciﬁcally recognized by the SAP30L antibody. In gel electro-
phoresis, a small ubiquitous band migrated at around 18 kDa
and thus slower than expected in order to represent the DEx2
or DEx2D5aa isoforms (DEx3,4 does not contain the VKS epi-
tope). It may have arisen from non-speciﬁc degradation or spe-
ciﬁc proteolytic cleavage of the full-length SAP30L protein
though we failed to prove this. The large proteins detected
by the VKS antibody could represent novel SAP30L splice
variants. In this respect, it is noteworthy that we have previ-
ously reported the presence of a large transcript of around
6 kb in Northern blotting using SAP30L-speciﬁc probe [9].
Furthermore, in chromosome 5 and upstream of SAP30L
gene, there is a gene for N-acetylgalactosaminyltransferase 10
(GALNT10) which is predicted by Geneid program to gener-
ate a fused mRNA with SAP30L. This prediction is, however,
awaiting experimental proof. Finally, since SAP30L is associ-
ated with a protein complex down-regulating gene expression,
the absence of wt SAP30L protein in cancer cells could indicate
it a crucial role in controlling transcription of genes driving e.g.
cell proliferation.
In summary, this study adds a new piece of information
regarding the molecular mechanisms inﬂuencing the transcrip-
tional repression of the Sin3A corepressor complex through
SAP30L, and highlights the intricacy of the regulatory mecha-
nism involved in DNA transcription.Acknowledgements: The authors thank Jorma Kulmala for technical
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